Demographic and clinical characteristics
| Demographic and hospitalisation characteristics | |
| Age in years, mean (range) (n=25) | 66 (45–96) |
| Gender (male:female) (n=25) | 1.6:1 |
| Hospitalisation length in days, mean (range) (n=25) | 11 (1–36) |
| Highest body temperature (°C), mean (range) (n=25) | 38.7 (35.3–40.2) |
| Hepatomegaly (n=25) | 12 (48%) |
| Splenomegaly (n=25) | 16 (64%) |
| Complete blood count at diagnosis (n=25) | |
| White cell count (K/µL), mean (range) | 6.9 (1.5–39.5) |
| Absolute neutrophil count (K/µL), mean (range) | 4.6 (0.03–37.1) |
| Absolute lymphocyte count (K/µL), mean (range) | 0.7 (0.0–2.9) |
| Absolute monocyte count (K/µL), mean (range) | 0.3 (0.0–2.0) |
| Haemoglobin (g/dL), mean (range) | 12.5 (5.5–19.7) |
| Platelets (K/µL), mean (range) | 156 (6–450) |
| Complete blood count at demise (n=25) | |
| White cell count (K/µL), mean (range) | 11.8 (0.3–64.9) |
| Absolute neutrophil count (K/µL), mean (range) | 8.6 (0.03–42.2) |
| Absolute lymphocyte count (K/µL), mean (range) | 0.8 (0.1–2.9) |
| Absolute monocyte count (K/µL), mean (range) | 0.8 (0.01–5.2) |
| Haemoglobin (g/dL), mean (range) | 8.9 (5.7–17.9) |
| Platelets (K/µL), mean (range) | 166 (10–642) |
| Cause of death (n=25) | |
| COVID-19 pneumonia (primary) | 19/25 (76%) |
| COVID-19 pneumonia (secondary) | 3/25 (12%) |
| Primary causes: acute leukaemia (2), gall bladder perforation (1) | |
| With COVID-19 infection | 2/25 (8%) |
| Primary causes: trauma, severe abdominal aortic atherosclerosis | |
| In the setting of documented COVID-19 PCR positivity | 1/25 (4%) |
| Primary cause: systemic amyloidosis with bilateral aspiration bronchopneumonia | |